Characterization of retrokeratoprosthetic membranes in the Boston type 1 keratoprosthesis

Archives of Ophthalmology

Volumn 129, Issue 3, 2011, Pages 310-316

  Stacy, Rebecca C ^a   Jakobiec, Frederick A ^a   Michaud, Norman A ^a   Dohlman, Claes H ^a   Colby, Kathryn A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CYTOKERATIN; EOSIN; HEMATOXYLIN; TOLONIUM CHLORIDE;

ACTIN FILAMENT; ADULT; AGED; ARTICLE; CASE REPORT; CHILD; CORNEA STROMA; DESCEMET MEMBRANE; EXCISION; EXPLANT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOPROSTHESIS; KERATOPROSTHESIS BOSTON TYPE 1; LENS EPITHELIUM; MALE; MEMBRANE; METAPLASIA; MYOFIBROBLAST; PETERS ANOMALY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROKERATOPROSTHETIC MEMBRANE; TRANSMISSION ELECTRON MICROSCOPY;

ACTINS; ADULT; AGED; ANTERIOR EYE SEGMENT; ARTIFICIAL ORGANS; CHILD, PRESCHOOL; CORNEA; CORNEAL OPACITY; DEVICE REMOVAL; EYE ABNORMALITIES; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANES; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS FAILURE; REOPERATION;

EID: 79952576394     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.26     Document Type: Article

References (25)

1. Doane MG, Dohlman CH, Bearse G. Fabrication of a keratoprosthesis. Cornea. 1996;15(2):179-184. (Pubitemid 26061316)
2. Khan BF, Harissi-Dagher M, Khan DM, Dohlman CH. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin. 2007;47(2):61-71.
3. Zerbe BL, Belin MW, Ciolino JB; Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113(10):1779, e1-e7.
4. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28(9):989-996.
5. Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology. 2009;116(4):640-651.
6. Dunlap K, Chak G, Aquavella JV, Myrowitz E, Utine CA, Akpek E. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology. 2010;117(4):687-692.
7. Bradley JC, Hernandez EG, Schwab IR, Mannis MJ. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea. 2009;28(3):321-327.
8. Dudenhoefer EJ, Nouri M, Gipson IK, et al. Histopathology of explanted collar button keratoprostheses: a clinicopathologic correlation. Cornea. 2003;22(5):424-428. (Pubitemid 36759036)
9. Bhat PV, Jakobiec FA, Papaliodis G, Sobrin L. Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation. Am J Ophthalmol. 2009;148(3):350-360.
10. Jakobiec FA, Mehta M, Iwamoto M, Hatton MP, Thakker M, Fay A. Intratarsal keratinous cysts of the Meibomian gland: distinctive clinicopathologic and immunohistochemical features in 6 cases. Am J Ophthalmol. 2010;149(1):82-94.
11. Jakobiec FA, Bhat P. Retrocorneal membranes: a comparative immunohistochemical analysis of keratocytic, endothelial, and epithelial origins. Am J Ophthalmol. 2010;150(2):230-242, e2.
12. Burris JE, Nordquist R, Rowsey JJ. Model of epithelial downgrowth, I: clinical correlations and light microscopy. Cornea. 1983;2(4):277-287. (Pubitemid 14019138)
13. Chen SH, Pineda R II. Epithelial and fibrous downgrowth: mechanisms of disease. Ophthalmol Clin North Am. 2002;15(1):41-48. (Pubitemid 34579201)
14. Chalam KV, Chokshi A, Agarwal S, Edward DP. Complications of AlphaCor keratoprosthesis: a clinicopathologic report. Cornea. 2007;26(10):1258-1260.
15. Lifshitz T, Oshry T, Rosenthal G. Retrocorneal membrane after penetrating keratoplasty. Ophthalmic Surg Lasers. 2001;32(2):159-161.
16. Mortemousque B, Dorot N, Poirier L, Williamson W, Brousse D, Verin P. Complication of keratoprosthesis of posterior fixation: retroprosthetic membranes: apropos of 4 cases. J Fr Ophtalmol. 1995;18(10):608-613.
17. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci. 1995;36(5):809-819.
18. Cockerham GC, Hidayat AA. Retrocorneal membrane with myofibroblasts after perforating injury: an immunohistochemical and ultrastructural study of 11 cases. Cornea. 1999;18(6):700-706. (Pubitemid 29522044)
19. Sherrard ES, Rycroft PV. Retrocorneal membranes, I: their origin and structure. Br J Ophthalmol. 1967;51(6):379-386.
20. Sherrard ES, Rycroft PV. Retrocorneal membranes, II: factors influencing their growth. Br J Ophthalmol. 1967;51(6):387-393.
21. Obata H, Tsuru T. Corneal wound healing from the perspective of keratoplasty specimens with special reference to the function of the Bowman layer and Descemet membrane. Cornea. 2007;26(9)(suppl 1):S82-S89. (Pubitemid 47442768)
22. Kurz GH, D'Amico RA. Histopathology of corneal graft failures. Am J Ophthalmol. 1968;66(2):184-199.
23. Banik R, Novick LH, Smith RE, Chuck RS. Retrocorneal membrane with Descemet's detachment. Cornea. 2001;20(7):763-764. (Pubitemid 34506479)
24. Prasher P, Muftuoglu O, Hsiao ML, Bowman RW, Hogan RN, Mootha VV. Epithelial downgrowth after Descemet stripping automated endothelial keratoplasty. Cornea. 2009;28(6):708-711.
25. Pineda R II, Jain V, Gupta P, Jakobiec FA. Descemet's stripping endothelial keratoplasty: an effective treatment for toxic anterior segment syndrome with histopathologic findings. Cornea. 2010;29(6):694-697.